Raymond James Downgrades Edwards Lifesciences (EW) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Raymond James softens on Edwards Lifesciences (EW) as confidence in growth profile begins to fade
February 6, 2023 10:35 AM ESTRaymond James downgraded Edwards Lifesciences Corp (NYSE: EW) to a Market Perform rating (From Outperform) as confidence in the companys growth profile begins to fade. EWs revenue growth has separated it from most of its peers and has long supported a premium valuation. However, analyst Jayson Bedford is... More
